The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: A Southwest Oncology Group Study

James K. Weick, John J. Crowley, Mohamed A. Hussein, Dennis F. Moore, Bart Barlogie

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: A Southwest Oncology Group Study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science